Diana S.M. Buist, PhD, MPH
Research interests and experience
- Cancer control: cancer screening and prevention; outreach and primary care prevention; comparative effectiveness; cost transparency; surveillance; secondary prevention; breast cancer treatment; breast cancer screening; outcomes following cancer diagnosis; cancer survivorship; provider variability in care
- Preventive medicine: cancer prevention and control; quality of care; preventive care; high-value care; consumer engagement in preventive medicine; systematic reviews
- Women's health: cancer prevention and control
- Aging & geriatrics: quality of care
What does optimal outreach, early detection, and preventive care for breast cancer look like? As a key member of two large research consortia focused on improving cancer screening and outcomes, Diana Buist is in a prime position to help answer this important question.
Dr. Buist is an epidemiologist and health services researcher whose work focuses primarily on early detection of breast cancer and reducing illness and death from breast cancer in populations. She is especially interested in translating research findings into clinically meaningful guidelines. Dr. Buist joined Group Health Research Institute (GHRI) in 1996 and within a few years became the Principal Investigator of the Group Health Breast Cancer Surveillance Project, one of seven sites participating in the National Cancer Institute's Breast Cancer Surveillance Consortium. She has also played a key role in several collaborative projects conducted by the HMO Cancer Research Network.
Her extensive experience working with these diverse data in longitudinal studies and randomized trials puts Dr. Buist in a unique position to examine cancer screening, care, and outcomes in health systems across the country. Because of her particular expertise in this area, she recently became a member of the Group Health-affiliated Evidence-based Practice Center—one of 11 centers funded by the Agency for Healthcare Research and Quality in 2012. Her role will include conducting systematic reviews for the U.S. Preventive Services Task Force.
Dr. Buist is an affiliate investigator at the Fred Hutchinson Cancer Research Center and an affiliate professor in the Departments of Epidemiology and Health Services at the University of Washington School of Public Health. She enjoys sharing her expertise by mentoring junior faculty and PhD and MPH candidates, co-directing the CRN Scholars Program, and teaching courses in clinical outcomes research internationally through the American Thoracic Society.
Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Deganan D, Buist DS, Rosenber MA, Alfisher M, Fletcher SW. Rapid increase in breast magnetic resonance imaging use: trends from 2000-2011. JAMA Intern Med. 2013 Nov 18. doi:10.1001/jamainternmed.2013.11958. [Epub ahead of print].
Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV, Cauley JA, Hue TF, LaCroix AZ, Falk RT, Pfeiffer R, Fuhrman BJ, Veenstra TD, Xu X, Brinton LA. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis. 2013 Nov 8. [Epub ahead of print]. PubMed
Carney PA, Geller BM, Bogart A, Sickles EA, Smith RA, Buist DS, Kerlikowske K, Onega TL, Miglioretti DL, Rosenberg R, Yankaskas BC. Feasibility and acceptability of conducting a randomized clinical trial designed to improve interpretation of screening mammography. Acad Radiol. 2013 Nov;20(11):1389-98. doi: 10.1016/j.acra.2013.08.017.
Buist DS, Bosco JL, Silliman RA, Gold HT, Field T, Yood MU, Quinn VP, Prout M, Lash TL. Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat. 2013 Oct 11 [Epub ahead of print]. PubMed
Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL. Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst. 2013 Sep 18;105(18):1373-84. PubMed
Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray SL, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev. 2013 Jul 5 [Epub ahead of print].
Chubak J, Yu O, Buist DS, Wirtz HS, Boudreau DM. Time scale in follow-up studies: considering disease prognosis. Epidemiology. 2013;24(4):628-9. doi: 10.1097/EDE.0b013e3182961708. PubMed
Onega T, Anderson ML, Miglioretti DL, Buist DS, Geller B, Bogart A, Smith RA, Sickles EA, Monsees B, Bassett L, Carney PA, Kerlikowske K, Yankaskas BC. Establishing a gold standard for test sets: variation in interpretive agreement of expert mammographers. Acad Radiol. 2013;20(6):731-9. doi: 10.1016/j.acra.2013.01.012. PubMed
Gold LS, Buist DS, Loggers ET, Etzioni R, Kessler L, Ramsey SD, Sullivan SD. Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington State. J Oncol Pract. 2013 May 28 [Epub ahead of print]. PubMed
Sprague BL, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist DS, Bowles EJ, Sisney GS, Burnside ES. Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res. 2013 May 27;15(3):R45 [Epub ahead of print]. PubMed
To view more publications, please see Dr. Buist's CV.